Source: Eur Respir Rev, 29 (156) 200114; 10.1183/16000617.0114-2020
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
Matthew John Robinson, Anna D. Krasnodembskaya. Therapeutic targeting of metabolic alterations in acute respiratory distress syndrome. Eur Respir Rev, 29 (156) 200114; 10.1183/16000617.0114-2020

Member's Comments

No comment yet.

Related content which might interest you: Phenotypes of acute respiratory distress syndrome Source: Virtual Congress 2021 – Respiratory critical care Year: 2021 Pathogenesis of acute microvascular lung injury and the acute respiratory distress syndrome Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=22 Year: 2002 Characterization of small airways structural alterations in acute respiratory distress syndrome Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 Acute respiratory distress syndrome  Source: International Congress 2017 – State of the art session: "Acute and chronic respiratory failure and sleep" Year: 2017 Acute respiratory distress syndrome Source: International Congress 2016 – Clinical year in review Year: 2016 Acute respiratory distress syndrome Source: Eur Respir Rev, 26 (144) 160116; 10.1183/16000617.0116-2016 Year: 2017 Corticosteroids in acute respiratory distress syndrome Source: Virtual Congress 2021 – Respiratory critical care Year: 2021 Early intervention with non-invasive respiratory therapies in mild acute respiratory distress syndrome secondary to COVID-19 Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19 Year: 2021 Neuregulin-1 as a potentially novel biomarker in acute respiratory distress syndrome Source: Eur Respir J 2013; 41: 259-261 Year: 2013 Acute increase in KL-6/MUC1 mucin as a potential trigger of disseminated intravascular coagulation in acute respiratory distress syndrome Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management Year: 2006 Current invasive ventilatory strategies in acute respiratory distress syndrome Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=161 Year: 2002 Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome Source: Eur Respir J 2003; 21: 720-727 Year: 2003 Severe acute respiratory distress syndrome due to ipilimumab Source: Eur Respir J 2013; 42: 866-868 Year: 2013 Mechanisms of exacerbation of respiratory symptoms in patients with metabolic syndrome Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Combined cell therapy and anticoagulants for acute respiratory distress syndrome Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Overview of current lung imaging in acute respiratory distress syndrome Source: Eur Respir Rev 2014; 23: 519-530 Year: 2014 Surfactant metabolism and replacement in acute respiratory distress syndrome Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=119 Year: 2002 Pneumonia and acute respiratory distress syndrome Source: Eur Respir Monogr 2015; 70: 141-157 Year: 2015